Clinical trial Recruiting at 1 site Observational Ages 18 to 50

Identifying genetic causes of heart issues in epilepsy patients

Official title: Genetic Markers of Cardiovascular Diseases and the Potential Role in Sudden Unexpected Death in Epilepsy.

Run by Mayo Clinic · NCT02824822 · Data updated 2026-11-12

This study is trying to find out if certain genetic factors can help explain why some young adults with epilepsy are at risk for sudden death.

Quick facts

Study typeObservational
Ages18 Years to 50 Years
SexAll
Enrollment600 (estimated)
SponsorMayo Clinic
Academic / other
Locations1 site (Rochester, Minnesota)
StatusRecruiting
StartedMay 2016
Main results expectedDecember 2031
Study endsDecember 2031
Registry record updatedNovember 3, 2026
Trial IDNCT02824822 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 to 50 with epilepsy or related conditions who are at high risk for sudden unexpected death.

Probably not a fit

Patients with seizures due to ischemic events or those with a history of cranial surgery or brain tumors may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the genetic factors that may contribute to sudden unexpected death in patients with epilepsy. It focuses on individuals aged 18 to 50 who are at high risk for sudden death due to their epilepsy or related conditions. Participants will be assessed using a risk scoring tool and may include blood relatives of patients with a history of epilepsy or cardiac issues. Genetic testing will be conducted using blood samples or buccal cells to identify potential underlying cardiovascular disorders.

Why it matters

Potential benefit: If successful, this study could lead to better understanding and prevention of sudden unexpected death in epilepsy patients.

How similar studies have gone: Other studies have shown promise in identifying genetic markers related to cardiovascular issues in epilepsy, suggesting this approach may yield valuable insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults ages 18 - 50 with a diagnosis of epilepsy or seizures, or syncope or drowning or cardiac arrest or sudden death or an abnormal ECG suggestive of an arrhythmia
* Blood-relatives (Aged 18+) of a patient with a history of epilepsy, seizure, cardiac arrest, sudden death, drowning, syncope or arrhythmia

Exclusion Criteria:

* Those who are unable to provide written consent.
* Prisoners (vulnerable population)
* Seizures secondary to ischemic events
* Traumatic brain injury resulting in seizures
* History of cranial surgery
* History of brain tumor

Where it's running

  • Mayo Clinic
    Rochester, Minnesota, United States
    Recruiting

Study contacts

  • Principal investigator: Virend K. Somers, MD PhD — Mayo Clinic
  • Study coordinator: Somers CPL Lab
  • Email: CPL@mayo.edu

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.